|
Derek Dykxhoorn
and Philip A. Sharp answer a few questions about this month's
new hot paper in the field of Molecular Biology & Genetics.
From
•>>September 2004
Field:
Molecular Biology & Genetics
Article Title: Killing the messenger: Short RNAs that silence gene expression
Authors: Dykxhoorn,
DM;Novina, CD;Sharp, PA
Journal: NAT REV MOL CELL BIOL
Volume: 4
Page: 457-467
Year: JUN 2003
* MIT, Ctr Canc Res, 40 Ames St, E17-529, Cambridge, MA 02139 USA.
* MIT, Ctr Canc Res, Cambridge, MA 02139 USA.
* MIT, Dept Biol, Cambridge, MA 02139 USA.
* MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA.
|
Why do you think your paper is highly cited?
|

“This paper provides a comprehensive overview of the rapidly developing field of RNA interference
(RNAi)...”
|
|
This paper provides a comprehensive overview of the rapidly
developing field of RNA interference (RNAi) by examining both the
basic biology of this gene regulation pathway and the development of
tools that allow for the application of this phenomenon for gene
silencing studies.
Does it describe a new discovery or new methodology that's useful
to others?
The discovery that small RNA molecules, termed short interfering (si)RNAs,
are capable of silencing gene expression has fundamentally changed our
understanding of the control of gene expression. These small RNA
molecules are capable of guiding a ribonucleoprotein complex, the
RNA-induced silencing complex (RISC), to the homologous mRNA, leading
to mRNA degradation or the repression of translation. This highly
conserved gene-silencing phenomenon, RNA interference, has been shown
to play a key role in the regulation of development and the protection
of an organism’s genome from invading pathogenic genetic elements.
The discovery of this regulatory mechanism has not only proven to be
an important biological process but has also allowed for the
development of novel gene silencing techniques that have facilitated
large scale gene function analysis, as well as opening the door for
potential therapeutic gene silencing.
Could you summarize the significance of your paper in layman's
terms?
The use of small RNA molecules (siRNAs) offers a highly specific
and effective method of silencing gene expression and holds a great
deal of promise as a therapeutic agent, inhibiting potentially harmful
gene products and pathogens.
How did you become involved in this research?
Research in the lab was already at the cutting edge of RNA biology,
including the study of RNA interference and its role in regulating
gene expressions, when I became interested in applying the principles
of RNAi for the therapeutic silencing of pathogenic genes, in
particular, for the silencing of HIV expression and replication.
Derek M. Dykxhoorn, Ph.D.
Lieberman Lab
CBR Institute for Biomedical Research
Harvard Medical School
Boston, MA, USA
Philip A. Sharp, Ph.D.
The McGovern Institute for Brain and Cognitive Sciences
The Center for Cancer Research
The Department of Biology
Massachusetts Institute of Technology
Cambridge, MA, USA
|
ESI Special Topics,
September 2004
Citing URL - http://www.esi-topics.com/nhp/2004/september-04-DerekDykxhoorn.html
|
|